Sheetal Hardikar, PhD, MBBS

Research Interests

  • Identifying and Evaluating Novel Molecular and Genetic Biomarkers for Cancer Risk and Prognosis of Gastrointestinal Cancers
  • The Role of Inflammation in Development, Prevention, and Progression of Gastrointestinal Cancers
  • Chronic Conditions Related to Inflammation, Including Obesity and Diabetes, and Their Role in the Development and Progression of Gastrointestinal Cancers
  • Cancer Screening Through Risk Stratification

Languages

  • English
  • Hindi
  • Marathi

Academic Information

  • Departments: Population Health Sciences - Assistant Professor
  • Divisions: Cancer Population Science

Academic Office Information

  • 801-213-6238
  • Huntsman Cancer Institute
    2000 Circle of Hope, Room: Room 4711
    Salt Lake City, UT 84112

Education History

Type School Degree
Research Fellow Fred Hutchinson Cancer Research Center
Cancer Prevention
Postdoctoral Research Fellow
Doctoral Training University of Washington School of Public Health
Epidemiology
Ph.D.
Graduate Training Ohio State University College of Public Health
Biostatistics
M.P.H.
Graduate Training Ohio State University College of Public Health
Epidemiology
M.S.
Professional Medical Maharashtra University of Health Sciences/TN Medical College & BYL Nair Charitable Hospital
Medicine
M.B.B.S.

Global Impact

Education History

Type School Degree Country
Professional Medical Maharashtra University of Health Sciences/TN Medical College & BYL Nair Charitable Hospital
Medicine
M.B.B.S. India

Selected Publications

Journal Article

  1. Yin H, Hardikar S, Lindstroem S, Hsu L, Anderson KE, Banbury BL, Berndt SI, Chan AT, Giovanucci EL, Harrison TA, Joshi AD, Nan H, Potter JD, Sakoda LC, Slattery ML, Schoen RE, White E, Peters U, Newcomb PA (2020). Telomere Maintenance Variants and Survival after Colorectal Cancer: Smoking- and Sex-Specific Associations. Cancer Epidemiol Biomarkers Prev, 29(9), 1817-1824.
  2. Hua X, Newcomb PA, Chubak J, Malen RC, Ziebell R, Kamineni A, Zhu LC, Upton MP, Wurscher MA, Thomas SS, Newman H, Hardikar S, Burnett-Hartman AN (2020). Associations between molecular characteristics of colorectal serrated polyps and subsequent advanced colorectal neoplasia. Cancer Causes Control, 31(7), 631-640.
  3. Viskochil R, Gigic B, Lin T, Skender S, Boehm J, Schrotz-King P, Steindorf K, Owen R, Figueiredo JC, Li CI, Siegel EM, Hardikar S, Shibata D, Toriola AT, Schneider M, Ulrich A, Ulrich CM, Ose J (2020). Associations between physical activity, sedentary behavior and urinary oxidized guanine in colorectal cancer patients: Results from the ColoCare Study. (Epub ahead of print) Appl Physiol Nutr Metab.
  4. Kiblawi R, Holowatyj AN, Gigic B, Brezina S, Geijsen AJMR, Ose J, Lin T, Hardikar S, Himbert C, Warby CA, Bhm J, Bours MJL, van Duijnhoven FJB, Gumpenberger T, Kok DE, Koole JL, van Roekel EH, Schrotz-King P, Ulvik A, Gsur A, Habermann N, Weijenberg MP, Ueland PM, Schneider M, Ulrich A, Ulrich CM, Playdon M (2020). One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients: results from the ColoCare Study. Br J Nutr, 123(10), 1187-1200.
  5. Hardikar S, Albrechtsen RD, Achaintre D, Lin T, Pauleck S, Playdon M, Holowatyj AN, Gigic B, Schrotz-King P, Boehm J, Habermann N, Brezina S, Gsur A, van Roekel EH, Weijenberg MP, Keski-Rahkonen P, Scalbert A, Ose J, Ulrich CM (2020). Impact of Pre-blood Collection Factors on Plasma Metabolomic Profiles. Metabolites, 10(5).
  6. Petrick JL, Li N, Anderson LA, Bernstein L, Corley DA, El Serag HB, Hardikar S, Liao LM, Liu G, Murray LJ, Rubenstein JH, Schneider JL, Shaheen NJ, Thrift AP, van den Brandt PA, Vaughan TL, Whiteman DC, Wu AH, Zhao WK, Gammon MD, Cook MB (2019). Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium. Cancer, 125(23), 4210-4223.
  7. Dashti SG, Li WY, Buchanan DD, Clendenning M, Rosty C, Winship IM, Macrae FA, Giles GG, Hardikar S, Hua X, Thibodeau SN, Figueiredo JC, Casey G, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Potter JD, Lindor NM, Hopper JL, Jenkins MA, Win AK (2019). Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome. Br J Cancer, 121(10), 869-876.
  8. Ose J, Gigic B, Lin T, Liesenfeld DB, Bhm J, Nattenmller J, Scherer D, Zielske L, Schrotz-King P, Habermann N, Ochs-Balcom HM, Peoples AR, Hardikar S, Li CI, Shibata D, Figueiredo J, Toriola AT, Siegel EM, Schmit S, Schneider M, Ulrich A, Kauczor HU, Ulrich CM (2019). Multiplatform Urinary Metabolomics Profiling to Discriminate Cachectic from Non-Cachectic Colorectal Cancer Patients: Pilot Results from the ColoCare Study. Metabolites, 9(9).
  9. Burnett-Hartman AN, Chubak J, Hua X, Ziebell R, Kamineni A, Zhu LC, Upton MP, Malen RC, Hardikar S, Newcomb PA (2019). The association between colorectal sessile serrated adenomas/polyps and subsequent advanced colorectal neoplasia. Cancer Causes Control, 30(9), 979-987.
  10. Holowatyj AN, Lewis MA, Pannier ST, Kirchhoff AC, Hardikar S, Figueiredo JC, Huang LC, Shibata D, Schmit SL, Ulrich CM (2019). Clinicopathologic and Racial/Ethnic Differences of Colorectal Cancer Among Adolescents and Young Adults. Clin Transl Gastroenterol, 10(7), e00059.